General Information of Drug (ID: DMSB0JA)

Drug Name
2-(4-Chloro-phenyl)-3H-imidazo[4,5-c]quinoline
Synonyms CHEMBL316782; SCHEMBL10771178; ZINC13756970
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL
#Ro5 Violations (Lipinski): 0 Molecular Weight (mw) 279.72
Logarithm of the Partition Coefficient (xlogp) 4
Rotatable Bond Count (rotbonds) 1
Hydrogen Bond Donor Count (hbonddonor) 1
Hydrogen Bond Acceptor Count (hbondacc) 2
Chemical Identifiers
Formula
C16H10ClN3
IUPAC Name
2-(4-chlorophenyl)-3H-imidazo[4,5-c]quinoline
Canonical SMILES
C1=CC=C2C(=C1)C3=C(C=N2)NC(=N3)C4=CC=C(C=C4)Cl
InChI
InChI=1S/C16H10ClN3/c17-11-7-5-10(6-8-11)16-19-14-9-18-13-4-2-1-3-12(13)15(14)20-16/h1-9H,(H,19,20)
InChIKey
CGBRMMMHBXSYHH-UHFFFAOYSA-N
Cross-matching ID
PubChem CID
10540663
TTD ID
D0V4AR

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
GABA(A) receptor alpha-1 (GABRA1) TT1MPAY GBRA1_HUMAN Inhibitor [1]
Gamma-aminobutyric acid receptor (GAR) TTNJYV2 NOUNIPROTAC Inhibitor [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 Synthesis and structure--activity relationships of fused imidazopyridines: a new series of benzodiazepine receptor ligands. J Med Chem. 1996 Jul 5;39(14):2844-51.